Nagy A, Szucs K, Grosz G, Sule M, Fekete F, Karoliny A
Heliyon. 2023; 9(8):e18859.
PMID: 37609397
PMC: 10440461.
DOI: 10.1016/j.heliyon.2023.e18859.
Hosogi H, Sakaguchi M, Yagi D, Onishi R, Hashimoto Y, Sakai Y
Langenbecks Arch Surg. 2021; 407(2):861-869.
PMID: 34775522
DOI: 10.1007/s00423-021-02377-5.
Zamanian Azodi M, Razzaghi M, Malekpour H, Rezaei-Tavirani M, Rezaei-Tavirani M, Heidari M
Gastroenterol Hepatol Bed Bench. 2021; 13(Suppl1):S68-S74.
PMID: 33585006
PMC: 7881399.
Mandovra P, Kalikar V, Patankar R
J Minim Access Surg. 2020; 17(4):458-461.
PMID: 32964875
PMC: 8486049.
DOI: 10.4103/jmas.JMAS_85_20.
Ciciora S, Woodley F
Paediatr Drugs. 2018; 20(6):523-537.
PMID: 30198060
DOI: 10.1007/s40272-018-0311-3.
Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study.
Miner Jr P, Silberg D, Ruth M, Miller F, Pandolfino J
BMC Gastroenterol. 2014; 14:188.
PMID: 25407279
PMC: 4289246.
DOI: 10.1186/1471-230X-14-188.
4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease.
Jirholt J, Asling B, Hammond P, Davidson G, Knutsson M, Walentinsson A
PLoS One. 2011; 6(4):e19095.
PMID: 21552517
PMC: 3084265.
DOI: 10.1371/journal.pone.0019095.
The size of the esophageal hiatus in gastroesophageal reflux pathophysiology: outcome of intraoperative measurements.
Batirel H, Uygur-Bayramicli O, Giral A, Ekici B, Bekiroglu N, Yildizeli B
J Gastrointest Surg. 2009; 14(1):38-44.
PMID: 19779943
DOI: 10.1007/s11605-009-1047-8.
Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.
Beaumont H, Jensen J, Carlsson A, Ruth M, Lehmann A, Boeckxstaens G
Br J Pharmacol. 2008; 156(1):153-62.
PMID: 19068079
PMC: 2697772.
DOI: 10.1111/j.1476-5381.2008.00010.x.
The role of GABA(A) receptors in the control of transient lower oesophageal sphincter relaxations in the dog.
Beaumont H, Jonsson-Rylander A, Carlsson K, Pierrou S, Ahlefelt M, Branden L
Br J Pharmacol. 2008; 153(6):1195-202.
PMID: 18204479
PMC: 2275437.
DOI: 10.1038/sj.bjp.0707681.
Long-term experience of treating 185 patients with gastroesophageal reflux disease (GERD) by anti-reflux surgery respecting the functional-morphological restoration of the esophagus.
Horstmann R, Classen C, Rottgermann S, Langer M, Palmes D
Langenbecks Arch Surg. 2005; 391(1):24-31.
PMID: 16328397
DOI: 10.1007/s00423-005-0002-8.
Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
Tonini M, De Giorgio R, De Ponti F
Drugs. 2004; 64(4):347-61.
PMID: 14969571
DOI: 10.2165/00003495-200464040-00001.
Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease.
Tam W, Schoeman M, Zhang Q, Dent J, Rigda R, Utley D
Gut. 2003; 52(4):479-85.
PMID: 12631654
PMC: 1773620.
DOI: 10.1136/gut.52.4.479.
Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up.
Mahmood Z, McMahon B, Arfin Q, Byrne P, Reynolds J, Murphy E
Gut. 2002; 52(1):34-9.
PMID: 12477756
PMC: 1773510.
DOI: 10.1136/gut.52.1.34.
Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease.
Omari T, Barnett C, Benninga M, Lontis R, Goodchild L, Haslam R
Gut. 2002; 51(4):475-9.
PMID: 12235066
PMC: 1773397.
DOI: 10.1136/gut.51.4.475.
Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
Zhang Q, Lehmann A, Rigda R, Dent J, Holloway R
Gut. 2002; 50(1):19-24.
PMID: 11772961
PMC: 1773078.
DOI: 10.1136/gut.50.1.19.
Pathophysiological mechanisms of gastroesophageal reflux disease in children.
Davidson G, Omari T
Curr Gastroenterol Rep. 2001; 3(3):257-62.
PMID: 11353563
DOI: 10.1007/s11894-001-0030-7.